Top Markets
Coin of the day
Neuropathix, Inc. Neuropathix, Inc.

Neuropathix, Inc.

NPTX
Rang in aandelen #41304
Neuropathix, Inc. is a biopharmaceutical firm dedicated to identifying,... Neuropathix, Inc. is a biopharmaceutical firm dedicated to identifying, advancing, and bringing to market innovative treatments derived from its exclusive platform of synthetic cannabinoid derivatives. The company's efforts are concentrated on the research and preclinical development of chemical compounds like KLS-13019, KLS-13023, and KLS-13022, alongside associated molecules and synthetic cannabidiol-based therapies. These investigational drugs are being explored for their potential application in treating various conditions, including chemotherapy-induced peripheral neuropathy, overt hepatic encephalopathy, mild traumatic brain injury, and chronic traumatic encephalopathy. Previously operating as Kannalife, Inc., the organization rebranded as Neuropathix, Inc. in November 2020. Established in 2010, Neuropathix, Inc. maintains its headquarters in Doylestown, Pennsylvania.
Aandeelprijs
$0.0003
Laatst gesynchroniseerd: 2023-06-13
Marktkapitalisatie
$28.14K
Verandering (1 dag)
0.00%
Verandering (1 jaar)
0.00%
Land
US
Handel Neuropathix, Inc. (NPTX)

Categorie

Koersgeschiedenis voor Neuropathix, Inc. (NPTX)
Hoogste slotkoers: $0.00 op 2023-06-01

Laagste slotkoers: $3.83 op 2019-12-01
Koersgeschiedenis van Neuropathix, Inc. van 2019 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
2023 -94.99%
2022 -87.62%
2021 -79.16%
2020 -93.93%
2019 0.00%
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
$524.82 32.56%
US
$872.59 34.95%
NL
$746.26 9.13%
CH
$1.08K -6.68%
KR
$260.84 17.08%
BE